(RTTNews) - Intelligent Bio Solutions Inc. (INBS), a medical technology company, and Princebuild, a UK based construction firm, announced on Tuesday a partnership to transition from saliva-based drug testing to INBS' Intelligent Fingerprinting Drug Screening System. This system will be implemented across Princebuild's seven UK sites, enhancing workplace safety, compliance, and employee privacy.
The fingerprint sweat-based drug testing solution is designed to provide fast, accurate results, detecting multiple substances simultaneously, and ensuring that employees are fit for duty at the time of testing.
Princebuild joins several other construction companies in adopting this technology, including Mount Anvil, Hayfield Homes, and Stonbury. The system's ease of use and shorter detection window provide a more efficient, non-invasive approach to workplace drug testing.
With over 400 global accounts in 19 countries, INBS continues to expand its footprint. The company is set to enter the U.S. market in 2025, following its recent FDA 510(k) submission in December 2024.
Currently, LGMK is trading at $1.29 down by 2.27%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
